Violetta Rosiek

Violetta Rosiek

Katowice, SL 40514, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

A somatostatin-producing neuroendocrine tumor at the duodenopancreatic interface in neurofibromatosis type 1.

A somatostatin-producing neuroendocrine tumor at the duodenopancreatic interface in neurofibromatosis type 1.

Journal: Polish archives of internal medicine
Published: August 13, 2026

Vitamin D Status and Gastroenteropancreatic Neuroendocrine Neoplasms: Biological Rationale, Clinical Associations and Limitations of Current Evidence.

Vitamin D Status and Gastroenteropancreatic Neuroendocrine Neoplasms: Biological Rationale, Clinical Associations and Limitations of Current Evidence.

Journal: Cancers
Published: June 08, 2026

Role of Inflammatory Cytokines Interleukin-1β and Interleukin-6 in Carcinogenesis, with Particular Emphasis on Gastroenteropancreatic Neuroendocrine Neoplasms.

Role of Inflammatory Cytokines Interleukin-1β and Interleukin-6 in Carcinogenesis, with Particular Emphasis on Gastroenteropancreatic Neuroendocrine Neoplasms.

Journal: Cancers
Published: May 17, 2026

Extended multiphasic computed tomography protocol improves detection of the primary tumor in neuroendocrine neoplasms of unknown primary: A single-center retrospective study.

Extended multiphasic computed tomography protocol improves detection of the primary tumor in neuroendocrine neoplasms of unknown primary: A single-center retrospective study.

Journal: European journal of radiology
Published: March 24, 2026

The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors.

The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors.

Journal: Nuclear medicine review. Central & Eastern Europe
Published: September 02, 2025

Breast neuroendocrine neoplasms - characteristics in contrast-enhanced mammography.

Breast neuroendocrine neoplasms - characteristics in contrast-enhanced mammography.

Journal: Endokrynologia Polska
Published: January 28, 2025

Angiogenic biomarkers of response to treatment with peptide receptor radionuclide therapy in neuroendocrine tumours.

Angiogenic biomarkers of response to treatment with peptide receptor radionuclide therapy in neuroendocrine tumours.

Journal: Endokrynologia Polska
Published: April 14, 2024

Ovarian metastasis in a patient with neuroendocrine tumour of the small intestine.

Ovarian metastasis in a patient with neuroendocrine tumour of the small intestine.

Journal: Endokrynologia Polska
Published: November 08, 2023

Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms.

Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms.

Journal: Cancers
Published: May 31, 2023

Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms.

Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms.

Journal: Journal of clinical medicine
Published: May 23, 2023

Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm.

Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm.

Journal: Cancers
Published: April 18, 2023

Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome.

Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome.

Journal: Cancers
Published: February 19, 2023
Showing 1-12 of 33

Last Updated: 09/26/2026